000 | 01034 a2200313 4500 | ||
---|---|---|---|
005 | 20250512034812.0 | ||
264 | 0 | _c19871016 | |
008 | 198710s 0 0 eng d | ||
022 | _a0277-6766 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFrey, J R | |
245 | 0 | 0 |
_aRecombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. _h[electronic resource] |
260 |
_bLymphokine research _c1987 |
||
300 |
_a215-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon Type I _xpharmacology |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aMonocytes _xdrug effects |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
700 | 1 | _aKamber, M | |
700 | 1 | _aPeck, R | |
773 | 0 |
_tLymphokine research _gvol. 6 _gno. 3 _gp. 215-27 |
|
999 |
_c3120367 _d3120367 |